Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/18/20 | 8-K | Current report filing |
|
38 | |
| 08/14/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
   |
308 |
| 08/03/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 07/31/20 | 8-K | Current report filing |
|
46 | |
| 07/24/20 | 8-K | Current report filing |
|
4 | |
| 07/08/20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
5 | |
| 07/08/20 | 8-K | Current report filing |
|
8 | |
| 06/26/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/26/20 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/26/20 | 4/A | Statement of changes in beneficial ownership of securities |
|
2 |
